| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.0047 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |